The amount of sales of cardiocerebral vascular drugs in China has shown an increasing trend, that is, it increased from 60.93 billion yuan in 2013 to 83.44 billion yuan in 2017, with a compound annual growth rate of 8.2%.
← all excerpts
Advances in Chemical Constituents, Clinical Applications, Pharmacology, Pharmacokinetics and Toxicology of <i>Erigeron breviscapus</i>.
1
—
—